Brookline Capital Acquisition Corp. has announced that, starting on February 22, holders of the 5,750,000 units sold in the company’s initial public offering may elect to separately trade shares of the Company’s common stock and warrants included in the units. Common stock and warrants that are separated will trade on the Nasdaq Capital Market under the symbols “BCAC” and “BCACW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on The Nasdaq Capital Markets under the symbol “BCACU.”
While the company may pursue an initial business combination target in any business or industry, it intends to focus its search on life science companies in the United States and Europe.